Skip to main content
. 2023 Oct 30;17:1234085. doi: 10.3389/fnhum.2023.1234085

Table 2.

Descriptive characteristics of study patients.

Study characteristics Total (n = 63) EEG-NF (n = 23)
Sociodemographics
Age, M (SD) 47.43 (13.27) 47.52 (14.44)
Female sex, % (n) 77% (49) 78% (18)
Education, % (n)
≥ 12 years 51% (32) 52% (12)
Clinical characteristics at baseline
BMI (kg/m2), M (SD) 36.65 (4.96) 36.55 (5.20)
Weight status, % (n)
Overweight (BMI 25 – < 30 kg/m2) 13% (8) 13% (3)
Obesity (BMI ≥ 30 kg/m2) 87% (55) 87% (20)
Eating disorder diagnosis (DSM-5)
BED, % (n) 81% (51) 83% (19)
BED of low frequency and/or limited duration, % (n) 19% (12) 17% (4)
Eating disorder symptoms
EDE binge-eating frequency past 28 days, M (SD) 3.21 (2.90) 2.87 (1.98)
Eating disorder psychopathology (EDE-Q global), M (SD) 2.74 (0.98) 2.96 (1.05)
Comorbidities
Depressive symptoms (PHQ-D), M (SD) 8.82 (4.11) 9.09 (4.96)
Anxiety symptoms (GAD-7 sum score), M (SD) 6.16 (4.31) 7.09 (4.87)
Treatment completion
Attended 12 sessions, % (n) 81% (51) 83% (16)

BMI, Body Mass Index; DSM-5, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (American Psychiatric Association, 2013); EDE, Eating Disorder Examination; EDE-Q, Eating Disorder Examination-Questionnaire (0–6* less favorable scores are asterisked); EEG-NF, electroencephalography. GAD-7, Generalized Anxiety Disorder 7-Item Scale (0–21*); PHQ–D, Patient Health Questionnaire–Depression Scale (0–27*).